Oncogenomics and the development of new cancer therapies - PubMed (original) (raw)
Review
. 2004 May 27;429(6990):469-74.
doi: 10.1038/nature02627.
Affiliations
- PMID: 15164073
- DOI: 10.1038/nature02627
Review
Oncogenomics and the development of new cancer therapies
Robert L Strausberg et al. Nature. 2004.
Abstract
Scientists have sequenced the human genome and identified most of its genes. Now it is time to use these genomic data, and the high-throughput technology developed to generate them, to tackle major health problems such as cancer. To accelerate our understanding of this disease and to produce targeted therapies, further basic mutational and functional genomic information is required. A systematic and coordinated approach, with the results freely available, should speed up progress. This will best be accomplished through an international academic and pharmaceutical oncogenomics initiative.
Similar articles
- An Experimental Approach to Genome Annotation: This report is based on a colloquium sponsored by the American Academy of Microbiology held July 19-20, 2004, in Washington, DC.
[No authors listed] [No authors listed] Washington (DC): American Society for Microbiology; 2004. Washington (DC): American Society for Microbiology; 2004. PMID: 33001599 Free Books & Documents. Review. - Oncogenomics: prospects for the future.
Sakatani T, Onyango P. Sakatani T, et al. Expert Rev Anticancer Ther. 2003 Dec;3(6):891-901. doi: 10.1586/14737140.3.6.891. Expert Rev Anticancer Ther. 2003. PMID: 14686710 Review. - Ethical and legal aspects of oncogenomics.
Stankov K, Draskovic D, Mikov M. Stankov K, et al. J BUON. 2012 Apr-Jun;17(2):383-8. J BUON. 2012. PMID: 22740222 - Cancer Informatics: New Tools for a Data-Driven Age in Cancer Research.
Kibbe W, Klemm J, Quackenbush J. Kibbe W, et al. Cancer Res. 2017 Nov 1;77(21):e1-e2. doi: 10.1158/0008-5472.CAN-17-2212. Cancer Res. 2017. PMID: 29092926 No abstract available. - Oncogenomics 2005 meeting report: dissecting cancer through genome research.
Feigal EG, Dracopoli NC, Trent JM. Feigal EG, et al. Cancer Res. 2005 Oct 1;65(19):8587-90. doi: 10.1158/0008-5472.CAN-05-2659. Cancer Res. 2005. PMID: 16204021
Cited by
- An Empirical Evaluation of Normalization Methods for MicroRNA Arrays in a Liposarcoma Study.
Qin LX, Tuschl T, Singer S. Qin LX, et al. Cancer Inform. 2013 Mar 18;12:83-101. doi: 10.4137/CIN.S11384. Print 2013. Cancer Inform. 2013. PMID: 23589668 Free PMC article. - Evolutionary concepts in biobanking - the BC BioLibrary.
Watson PH, Wilson-McManus JE, Barnes RO, Giesz SC, Png A, Hegele RG, Brinkman JN, Mackenzie IR, Huntsman DG, Junker A, Gilks B, Skarsgard E, Burgess M, Aparicio S, McManus BM. Watson PH, et al. J Transl Med. 2009 Nov 12;7:95. doi: 10.1186/1479-5876-7-95. J Transl Med. 2009. PMID: 19909513 Free PMC article. - Pyruvate kinase M2 and the mitochondrial ATPase Inhibitory Factor 1 provide novel biomarkers of dermatomyositis: a metabolic link to oncogenesis.
Santacatterina F, Sánchez-Aragó M, Catalán-García M, Garrabou G, de Arenas CN, Grau JM, Cardellach F, Cuezva JM. Santacatterina F, et al. J Transl Med. 2017 Feb 10;15(1):29. doi: 10.1186/s12967-017-1136-5. J Transl Med. 2017. PMID: 28183315 Free PMC article. - Cancer metabolism: strategic diversion from targeting cancer drivers to targeting cancer suppliers.
Kim SY. Kim SY. Biomol Ther (Seoul). 2015 Mar;23(2):99-109. doi: 10.4062/biomolther.2015.013. Epub 2015 Mar 1. Biomol Ther (Seoul). 2015. PMID: 25767677 Free PMC article. Review. - Recent progress of metal-based nanomaterials with anti-tumor biological effects for enhanced cancer therapy.
Lei H, Pei Z, Jiang C, Cheng L. Lei H, et al. Exploration (Beijing). 2023 Jun 30;3(5):20220001. doi: 10.1002/EXP.20220001. eCollection 2023 Oct. Exploration (Beijing). 2023. PMID: 37933288 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources